Skip to main content

Table 4 Distribution of the studied cases as per SVR

From: Assessment of carotid atherosclerosis in Egyptian chronic hepatitis C patients after treatment by direct-acting antiviral drugs

  Studied patients
(no. = 80)
No %
SVR Nonresponders 3 3.75%
Responders 77 96.25%
  1. Fifty-six (70%) patients were treated by SOF/DAC regimen, while 24 (30%) patients were treated by SOF/DAC/RBV regimen